179 related articles for article (PubMed ID: 23318434)
21. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.
Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K
Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524
[TBL] [Abstract][Full Text] [Related]
22. The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells.
Zeng C; Liu S; Lu S; Yu X; Lai J; Wu Y; Chen S; Wang L; Yu Z; Luo G; Li Y
Mol Cancer; 2018 Aug; 17(1):130. PubMed ID: 30153828
[TBL] [Abstract][Full Text] [Related]
23. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R
Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125
[TBL] [Abstract][Full Text] [Related]
24. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
25. Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells.
Abraham SA; Hopcroft LE; Carrick E; Drotar ME; Dunn K; Williamson AJ; Korfi K; Baquero P; Park LE; Scott MT; Pellicano F; Pierce A; Copland M; Nourse C; Grimmond SM; Vetrie D; Whetton AD; Holyoake TL
Nature; 2016 Jun; 534(7607):341-6. PubMed ID: 27281222
[TBL] [Abstract][Full Text] [Related]
26. The tyrosine phosphatase TC48 interacts with and inactivates the oncogenic fusion protein BCR-Abl but not cellular Abl.
Mitra A; Sasikumar K; Parthasaradhi BV; Radha V
Biochim Biophys Acta; 2013 Jan; 1832(1):275-84. PubMed ID: 23124138
[TBL] [Abstract][Full Text] [Related]
27. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
28. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.
Nakatsu Y; Sakoda H; Kushiyama A; Zhang J; Ono H; Fujishiro M; Kikuchi T; Fukushima T; Yoneda M; Ohno H; Horike N; Kanna M; Tsuchiya Y; Kamata H; Nishimura F; Isobe T; Ogihara T; Katagiri H; Oka Y; Takahashi S; Kurihara H; Uchida T; Asano T
J Biol Chem; 2011 Jun; 286(23):20812-22. PubMed ID: 21454638
[TBL] [Abstract][Full Text] [Related]
29. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.
Arnold HK; Zhang X; Daniel CJ; Tibbitts D; Escamilla-Powers J; Farrell A; Tokarz S; Morgan C; Sears RC
EMBO J; 2009 Mar; 28(5):500-12. PubMed ID: 19131971
[TBL] [Abstract][Full Text] [Related]
30. Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis.
Chen HZ; Li L; Wang WJ; Du XD; Wen Q; He JP; Zhao BX; Li GD; Zhou W; Xia Y; Yang QY; Hew CL; Liou YC; Wu Q
Oncogene; 2012 Jun; 31(23):2876-87. PubMed ID: 22002310
[TBL] [Abstract][Full Text] [Related]
31. Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals.
Su Y; Pelz C; Huang T; Torkenczy K; Wang X; Cherry A; Daniel CJ; Liang J; Nan X; Dai MS; Adey A; Impey S; Sears RC
Genes Dev; 2018 Nov; 32(21-22):1398-1419. PubMed ID: 30366908
[TBL] [Abstract][Full Text] [Related]
32. Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors.
Boureux A; Furstoss O; Simon V; Roche S
J Cell Sci; 2005 Aug; 118(Pt 16):3717-26. PubMed ID: 16076903
[TBL] [Abstract][Full Text] [Related]
33. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
[TBL] [Abstract][Full Text] [Related]
34. Functional phosphoproteomic analysis reveals cold-shock domain protein A to be a Bcr-Abl effector-regulating proliferation and transformation in chronic myeloid leukemia.
Sears D; Luong P; Yuan M; Nteliopoulos G; Man YK; Melo JV; Basu S
Cell Death Dis; 2010 Nov; 1(11):e93. PubMed ID: 21368869
[TBL] [Abstract][Full Text] [Related]
35. The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP.
Mantovani F; Tocco F; Girardini J; Smith P; Gasco M; Lu X; Crook T; Del Sal G
Nat Struct Mol Biol; 2007 Oct; 14(10):912-20. PubMed ID: 17906639
[TBL] [Abstract][Full Text] [Related]
36. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
Sharma N; Magistroni V; Piazza R; Citterio S; Mezzatesta C; Khandelwal P; Pirola A; Gambacorti-Passerini C
Mol Cancer; 2015 Jul; 14():132. PubMed ID: 26179066
[TBL] [Abstract][Full Text] [Related]
37. 14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.
Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Santucci MA
Traffic; 2009 Jun; 10(6):637-47. PubMed ID: 19220809
[TBL] [Abstract][Full Text] [Related]
38. Pre-Anchoring of Pin1 to Unphosphorylated c-Myc in a Fuzzy Complex Regulates c-Myc Activity.
Helander S; Montecchio M; Pilstål R; Su Y; Kuruvilla J; Elvén M; Ziauddin JME; Anandapadamanaban M; Cristobal S; Lundström P; Sears RC; Wallner B; Sunnerhagen M
Structure; 2015 Dec; 23(12):2267-2279. PubMed ID: 26655473
[TBL] [Abstract][Full Text] [Related]
39. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
40. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.
Gorre ME; Mohammed M; Ellwood K; Hsu N; Paquette R; Rao PN; Sawyers CL
Science; 2001 Aug; 293(5531):876-80. PubMed ID: 11423618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
